Scientific Congress
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
TV NATIONAL HONOREES 60 Minutes: the Chibok Girls (60
TV NATIONAL HONOREES 60 Minutes: The Chibok Girls (60 Minutes) Clarissa Ward (CNN International) CBS News CNN International News Magazine Reporter/Correspondent Abby McEnany (Work in Progress) Danai Gurira (The Walking Dead) SHOWTIME AMC Actress in a Breakthrough Role Actress in a Leading Role - Drama Alex Duda (The Kelly Clarkson Show) Fiona Shaw (Killing Eve) NBCUniversal BBC AMERICA Showrunner – Talk Show Actress in a Supporting Role - Drama Am I Next? Trans and Targeted Francesca Gregorini (Killing Eve) ABC NEWS Nightline BBC AMERICA Hard News Feature Director - Scripted Angela Kang (The Walking Dead) Gender Discrimination in the FBI AMC NBC News Investigative Unit Showrunner- Scripted Interview Feature Better Things Grey's Anatomy FX Networks ABC Studios Comedy Drama- Grand Award BookTube Izzie Pick Ibarra (THE MASKED SINGER) YouTube Originals FOX Broadcasting Company Non-Fiction Entertainment Showrunner - Unscripted Caroline Waterlow (Qualified) Michelle Williams (Fosse/Verdon) ESPN Films FX Networks Producer- Documentary /Unscripted / Non- Actress in a Leading Role - Made for TV Movie Fiction or Limited Series Catherine Reitman (Workin' Moms) Mission Unstoppable Wolf + Rabbit Entertainment (CBC/Netflix) Produced by Litton Entertainment Actress in a Leading Role - Comedy or Musical Family Series Catherine Reitman (Workin' Moms) MSNBC 2019 Democratic Debate (Atlanta) Wolf + Rabbit Entertainment (CBC/Netflix) MSNBC Director - Comedy Special or Variety - Breakthrough Naomi Watts (The Loudest Voice) Sharyn Alfonsi (60 Minutes) SHOWTIME -
134TH COMMENCEMENT James E
134 th Commencement MAY 2021 Welcome Dear Temple graduates, Congratulations! Today is a day of celebration for you and all those who have supported you in your Temple journey. I couldn’t be more proud of the diverse and driven students who are graduating this spring. Congratulations to all of you, to your families and to our dedicated faculty and academic advisors who had the pleasure of educating and championing you. If Temple’s founder Russell Conwell were alive to see your collective achievements today, he’d be thrilled and amazed. In 1884, he planted the seeds that have grown and matured into one of this nation’s great urban research universities. Now it’s your turn to put your own ideas and dreams in motion. Even if you experience hardships or disappointments, remember the motto Conwell left us: Perseverantia Vincit, Perseverance Conquers. We have faith that you will succeed. Thank you so much for calling Temple your academic home. While I trust you’ll go far, remember that you will always be part of the Cherry and White. Plan to come back home often. Sincerely, Richard M. Englert President UPDATED: 05/07/2021 Contents The Officers and the Board of Trustees ............................................2 Candidates for Degrees James E. Beasley School of Law ....................................................3 Esther Boyer College of Music and Dance .....................................7 College of Education and Human Development ...........................11 College of Engineering ............................................................... -
Reproductive MEDICINE Approximately One in Six Couples Will Experience Difficulty Conceiving
reproductive MEDICINE Approximately one in six couples will experience difficulty conceiving. Our team can help. Welcome to the CMC Center for Reproductive Medicine at CMC Women’s Institute. From the moment you enter our office, you will experience the warm and welcoming atmosphere, the expert medical care and the success that truly makes the CMC Center for Reproductive Medicine one of the best centers in the region. Our physicians have over 50 years combined experience and are the only all board-certified Reproductive Endocrinology and Infertility team near Charlotte. Whether your infertility issue is simple or complex, our caring team will do everything it can to help you achieve your dream of having a baby. “The nurses are your biggest cheerleaders, and the doctors are your rock which helps you through to the next steps. Whenever I see my girls smile and giggle, every shot, test and office visit suddenly becomes a part of the story of how our family was created. There are no words to express my gratitude for the doctors and staff at CMC Center for Reproductive Medicine.” -Melissa Harrison Highly Trained When “high tech” treatment is needed, our physicians provide comprehensive care, seeking out the most effective new technologies with the best trained andrology and embryology specialists in the region. Our services include: Fertility Services • Intrauterine sperm inseminations (IUI) We believe that open communication is one of the most important elements of fertility • In vitro fertilization (IVF) treatment. This is why our entire staff is committed to listening to your concerns and • Donor egg program keeping you fully informed throughout your entire treatment plan. -
Reproductive Endocrinology and Infertility the American Board of Obstetrics and Gynecology, Inc
1 2019 Bulletin for Subspecialty Certification in Reproductive Endocrinology and Infertility The American Board of Obstetrics and Gynecology, Inc. 2915 Vine St., Dallas, TX 75204 First in Women’s Health This Bulletin, issued in January 2018, represents the official statement of the 2019 requirements for subspecialty certification in Reproductive Endocrinology and Infertility 2 Important Information for all Candidates 1. Beginning in calendar year 2020, all physicians who have completed an ABOG or ACGME fellowship in Reproductive Endocrinology and Infertility must achieve ABOG subspecialty certification within 8 years of completion of their training. If certification is not achieved within 8 years, the physician no longer will be eligible to apply for either the qualifying or certifying subspecialty examination unless an additional 6 months of subspecialty training is completed. Physicians who have completed subspecialty training in calendar year 2012 or earlier must be subspecialty certified by 2020 or will be required to complete an additional 6 months of training before regaining eligibility to apply for certification. 2. The preparation of case lists for the Certifying Examination has changed. Candidates will no longer submit paper case lists. Rather, submission will be electronic. Candidates MUST use the electronic reproductive endocrinology and infertility case list forms that will be posted on their ABOG Personal Page in early 2018. 3. Fellows may take up to 8 weeks off each of the fellowship years. The total time off may not exceed 15 weeks over the three years. 4. All fees must be paid by credit card through the ABOG website (www.abog.org) and are payable in US Dollars only. -
Gonadotropin Therapy in Assisted Reproduction: an Evolutionary Perspective from Biologics to Biotech
REVIEW Gonadotropin therapy in assisted reproduction: an evolutionary perspective from biologics to biotech Roge´rio de Barros F. Lea˜ o, Sandro C. Esteves Andrology & Human Reproduction Clinic (ANDROFERT), Referral Center for Male Reproduction, Campinas/SP, Brazil. Gonadotropin therapy plays an integral role in ovarian stimulation for infertility treatments. Efforts have been made over the last century to improve gonadotropin preparations. Undoubtedly, current gonadotropins have better quality and safety profiles as well as clinical efficacy than earlier ones. A major achievement has been introducing recombinant technology in the manufacturing processes for follicle-stimulating hormone, luteinizing hormone, and human chorionic gonadotropin. Recombinant gonadotropins are purer than urine- derived gonadotropins, and incorporating vial filling by mass virtually eliminated batch-to-batch variations and enabled accurate dosing. Recombinant and fill-by-mass technologies have been the driving forces for launching of prefilled pen devices for more patient-friendly ovarian stimulation. The most recent developments include the fixed combination of follitropin alfa + lutropin alfa, long-acting FSH gonadotropin, and a new family of prefilled pen injector devices for administration of recombinant gonadotropins. The next step would be the production of orally bioactive molecules with selective follicle-stimulating hormone and luteinizing hormone activity. KEYWORDS: Gonadotropins; Ovulation Induction; Assisted Reproductive Techniques; Systematic Review. -
Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) Revised Glossary on ART Terminology, 2009†
Human Reproduction, Vol.24, No.11 pp. 2683–2687, 2009 Advanced Access publication on October 4, 2009 doi:10.1093/humrep/dep343 SIMULTANEOUS PUBLICATION Infertility The International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) Revised Glossary on ART Terminology, 2009† F. Zegers-Hochschild1,9, G.D. Adamson2, J. de Mouzon3, O. Ishihara4, R. Mansour5, K. Nygren6, E. Sullivan7, and S. van der Poel8 on behalf of ICMART and WHO 1Unit of Reproductive Medicine, Clinicas las Condes, Santiago, Chile 2Fertility Physicians of Northern California, Palo Alto and San Jose, California, USA 3INSERM U822, Hoˆpital de Biceˆtre, Le Kremlin Biceˆtre Cedex, Paris, France 4Saitama Medical University Hospital, Moroyama, Saitana 350-0495, JAPAN 53 Rd 161 Maadi, Cairo 11431, Egypt 6IVF Unit, Sophiahemmet Hospital, Stockholm, Sweden 7Perinatal and Reproductive Epidemiology and Research Unit, School Women’s and Children’s Health, University of New South Wales, Sydney, Australia 8Department of Reproductive Health and Research, and the Special Program of Research, Development and Research Training in Human Reproduction, World Health Organization, Geneva, Switzerland 9Correspondence address: Unit of Reproductive Medicine, Clinica las Condes, Lo Fontecilla, 441, Santiago, Chile. Fax: 56-2-6108167, E-mail: [email protected] background: Many definitions used in medically assisted reproduction (MAR) vary in different settings, making it difficult to standardize and compare procedures in different countries and regions. With the expansion of infertility interventions worldwide, including lower resource settings, the importance and value of a common nomenclature is critical. The objective is to develop an internationally accepted and continually updated set of definitions, which would be utilized to standardize and harmonize international data collection, and to assist in monitoring the availability, efficacy, and safety of assisted reproductive technology (ART) being practiced worldwide. -
Parviz K. Kavoussi, M.D., F.A.C.S. Reproductive Urologist
PARVIZ K. KAVOUSSI, M.D., F.A.C.S. REPRODUCTIVE UROLOGIST www.AustinFertility.com www.AustinVasecomyCenter.com www.WestlakeIVF.com www.AustinMensHealth.com WESTLAKE LOCATION: 300 BEARDSLEY LANE Building B, SUITE 200 AUSTIN, TX 78746 SOUTH AUSTIN LOCATION: 4303 JAMES CASEY, SUITE B AUSTIN, TEXAS 78745 ROUND ROCK LOCATION: 7700 CAT HOLLOW DRIVE, SUITE 106 ROUND ROCK, TEXAS 78681 Phone: (512) 444-1414 EXT 2 Fax: (512) 441-1202 POSTDOCTORAL TRAINING THE UNIVERSITY OF VIRGINIA HEALTH SCIENCES CENTER. Charlottesville, Virginia. Fellowship- Reproductive Urology/Andrology – Male Infertility, Sexual Medicine, and Microsurgery (Vasectomy Reversals/Sperm Retrievals). National Institute of Health funded fellow. July 2008-June 2010. BAYLOR SCOTT & WHITE MEMORIAL HOSPITAL AND HEALTH SCIENCES CENTER. Temple, Texas. Residency- Urology- July 2004-June 2008. General Surgery July 2002-June 2004 EDUCATION THE UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON. Galveston, Texas. Doctor of Medicine. August 1998-May 2002. BAYLOR UNIVERSITY. Waco, Texas. Bachelor of Arts, degree in Biology. August 1994-May 1998. BOARD CERTIFICATION The American Board of Urology ACADEMIC APPOINTMENTS • Adjunct Assistant Professor. Department of Urology. University of Texas Health Sciences Center at San Antonio. September 2015-present. • Adjunct Assistant Professor. Department of Psychology, Division of Neuroendocrinology and Motivation. University of Texas at Austin. March 2013- present. SPECIALTY CREDENTIALS RAMSES. Credentialed in Robot Assisted Microsurgery in Urology/Robot Assisted Vasectomy Reversals by RAMSES (Robot Assisted Microsurgical and Endoscopic Society). Winter Haven Hospital & University of Florida. April 2011. LABORATORY EXPERIENCE • Basic science laboratory research in the Department of Urology at University of Virginia funded via NIH training grant. July 2008-June 2010. • Non-human primate surgery at the Michael E. -
Is There an Ideal Stimulation for Poor Ovarian Reserve?
Evidence-based treatment of POR and POF Norbert Gleicher, MD Medical Director and Chief Scientist, Center For Human Reproduction, New York, NY President, Foundation For Reproductive Medicine, New York, NY Guest Investigator, Rockefeller University, New York, NY Professor (Adj), Department Of Obstetrics & Gynecology, Vienna University School Of Medicine, Vienna, Austria Ovarian Club X and CoGEN in Asia | December 16-17, 2017 | Hong Kong Conflict Statement Dr. Gleicher is listed as co-inventor on a number of pending patent applications claiming diagnostic and therapeutic benefits from determination of CGG repeat numbers and ovarian FMR1 genotypes and sub-genotypes. Dr. Gleicher is co-inventor of awarded U.S. patents, claiming therapeutic benefits for supplementation of DHEA in women with diminished ovarian reserve, a topic discussed in this talk. Other patent applications in regards to DHEA and other fertility-related claims, with no relationship to this talk, are pending. Dr. Gleicher receives royalties from, and owns shares in Fertility Neutraceuticals, LLC, a distributor of a DHEA product. Index • Defining functional ovarian reserve • Preparing the ovaries • Androgens • HGH • Stimulating the ovaries • Embryology • What can be achieved FSH and Androgen Receptors Reproductive Biology and Endocrinology 2011, 9:116 doi:10.1186/1477-7827-9-116 Activity of HGH (via IGF-I) • FSH and IGF-I synergistically stimulate steroid production → Silencing the IGF-gene leads to infertility and/or hypogonadism • Well-known effects of FSH on Cyp19 and AKT -
Star Awards S01 TB 2209 2017 Start Layout 1 20/09/2017 12:10 Page 2
TB 2209 2016 Cover Copy 20/09/2017 11:47 Page 1 September 22 2017 | ISSUE NO 2,031 | travelbulletin.co.uk Celebrating 21 Spectacular Years of Star Awards S01 TB 2209 2017 Start_Layout 1 20/09/2017 12:10 Page 2 Thank Yo u Jetset are immensely proud and grateful to be working solely with the trade. We also vow never to take for granted your support…and votes! www.jetsetflights.co.uk S01 TB 2209 2017 Start_Layout 1 20/09/2017 14:29 Page 3 newsbulletin Great Scots..! FLYBE’S NEW joint venture flights with alliance partner, Eastern Airways, has taken to the skies for the first time in Scotland. Europe’s largest regional airline will provide a continuation of six branded Flybe routes now operated by Eastern Airways’ aircraft from Sumburgh to Aberdeen, Edinburgh and Glasgow, Aberdeen to Kirkwall and from Glasgow to Stornoway and Manchester. The airlines’ partnership will also see the Embraer 170 jet service operating on Shetland routes for the first time, shaving some 30-minutes off the recognised flight times.Pictured at Aberdeen Airport celebrating the new Aberdeen to Sumburgh route are, from the left: John Twiss, Flybe; pilot Ruben Ter Brake; Tony Burgess, Eastern Airways; Christine Ourmieres-Widener, Flybe; cabin attendant Julia Ritchie; David Paterson, Flybe; and Mathew Herberg, Eastern Airways. Brits waste up to a day of their holiday on social media Expedia research reveals DATA RELEASED by Expedia has revealed that the paid more attention than normal to their social media average Brit wastes more than nine hours during a accounts whilst on holiday. -
Accuracy of Assessing Embryo Ploidy of Human Embryos with PGS in Association with IVF
Accuracy of assessing embryo ploidy of human embryos with PGS in association with IVF Norbert Gleicher, MD Medical Director And Chief Scientist, Center For Human Reproduction, New York, NY President, Foundation For Reproductive Medicine, New York, NY Professor (Adj), Rockefeller University, New York, NY Professor (Adj), Department Of Obstetrics & Gynecology, Vienna University School Of Medicine, Vienna, Austria AAB College of Reproductive Biology Symposium, Houston, TX, May 15-18, 2017 Conflict Statement Dr. Gleicher is listed as co-inventor on a number of pending patent applications claiming diagnostic and therapeutic benefits from determination of CGG repeat numbers and ovarian FMR1 genotypes and sub-genotypes. Dr. Gleicher is co-inventor of awarded U.S. patents, claiming therapeutic benefits for supplementation of DHEA in women with diminished ovarian reserve, a topic discussed in this talk. Other patent applications in regards to DHEA and other fertility-related claims, with no relationship to this talk, are pending. Dr. Gleicher receives royalties from, and owns shares in Fertility Neutraceuticals, LLC, a distributor of a DHEA product. Dr. Gleicher is co-inventor of three pending patent applications claiming potential therapeutic benefit for anti-Müllerian hormone (AMH) in infertile women. Dr. Gleicher owns shares in OvaNova Laboratories, LLC. Outline . The PGS hypothesis . Assumptions underlying PGS . Mathematical evidence that PGS cannot work . Experimental evidence that PGS cannot work . Clinical evidence that PGS does not work Outline . The PGS hypothesis . Assumptions underlying PGS . Mathematical evidence that PGS cannot work . Experimental evidence that PGS cannot work . Clinical evidence that PGS does not work The PGS Hypothesis . Aneuploidy is a major cause of IVF failure and miscarriages after IVF . -
ABC Audio End-Of-Year Programming
Dec. 16, 2019 ABC AUDIO ANNOUNCES END-OF-YEAR PROGRAMMING 2019 Four Long-Form Programs, Eight Short-Form News Series and a Music Special As 2019 comes to an end, ABC Audio announces a wealth of end-of-year programming, including four long-form programs featuring top news stories, interviews and major events from the past year; eight short-form series looking at the year in politics, entertainment, health, sports and more; and a music special, “2019 Rewind: The Biggest Country Hits of the Year,” hosted by country star Morgan Wallen. Long-Form Programs: • “Playback 2019” is a one-hour special anchored by ABC News correspondents Cheri Preston and Aaron Katersky taking an in-depth look at the biggest stories of the year. • “2019: The Year in Review” is a three-hour retrospective of some of the year’s top stories, told through highlights of ABC News Radio’s live breaking news coverage. Hear how some of the biggest events of the year unfolded. This show also includes interviews with newsmakers, highlights from the award-winning podcast “Start Here” and analysis from FiveThirtyEight. • “Perspective” is a special decade-end edition of ABC News Radio’s weekly newsmagazine exploring the biggest stories of the 2010s. • “World News This Year” is a special edition of the regular show, “World News This Week,” and will recap the last 52 weeks of our lives. Short-Form Series: • “2019 in Review” looks back at the biggest stories of 2019, including the tragic mass shootings in El Paso, Texas; Dayton, Ohio; and elsewhere. The program also explores the economy and trade war, the college admissions cheating scandal and the curious case of Jussie Smollett. -
The Evolution of Our Understanding of Human Development Over the Last 10 Years ✉ Ali H
COMMENT https://doi.org/10.1038/s41467-021-24793-3 OPEN The evolution of our understanding of human development over the last 10 years ✉ Ali H. Brivanlou 1 & Norbert Gleicher 2,3,4 As it fulfills an irresistible need to understand our own origins, research on human development occupies a unique niche in scientific and medical research. 1234567890():,; In this Comment, we explore the progress in our understanding of human development over the past 10 years. The focus is on basic research, clinical applications, and ethical considerations. What basic research has taught us about human development Over the last decade, progress in understanding our own development was mostly driven by the emergence and combination of remarkable new technologies. New molecular biology tools such as single-cell RNA-sequencing (sc-RNA-seq) unveiled the earliest genetic signature of the three cell lineages of the human blastocyst and allowed for the discovery of human-specific signatures1–3. CRISPR/Cas9 genome editing has offered further access to in vitro functional studies in human blastocysts4. However, as we discuss below, an ethical line was crossed when a group claimed that genetically modified human embryos had been transferred, leading to births5 when neither public opinion nor a consensus within the scientific community had been reached regarding whether crossing the germline in in vitro fertilization (IVF) was safe and ethically acceptable. On the embryology side, the development of an in vitro attachment platform for human blastocysts offered a first glance into post-implantation events up to 12 days1,3,5,6. This paved the way for several important discoveries, including the observation that the human embryo can self- organize to generate embryonic and extraembryonic germ layers, yolk sac, and amniotic cavities in the absence of maternal influences5,6; and the presence of a transient embryonic tissue of trophectodermal lineage, adjacent to the yolk sac, therefore named, yolk-sac trophectoderm (ysTE)5.